These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28494927)

  • 41. Effect of calf age and administration route of initial multivalent modified-live virus vaccine on humoral and cell-mediated immune responses following subsequent administration of a booster vaccination at weaning in beef calves.
    Woolums AR; Berghaus RD; Berghaus LJ; Ellis RW; Pence ME; Saliki JT; Hurley KA; Galland KL; Burdett WW; Nordstrom ST; Hurley DJ
    Am J Vet Res; 2013 Feb; 74(2):343-54. PubMed ID: 23363363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Milk production and reproductive performance in dairy cows given bovine respiratory syncytial virus vaccine prior to parturition.
    Ferguson JD; Galligan DT; Cortese V
    J Am Vet Med Assoc; 1997 Jun; 210(12):1779-83. PubMed ID: 9187730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective immunity following vaccination with a recombinant multiple-epitope protein of bovine herpesvirus type I in a rabbit model.
    Wen X; Tong X; Wang M; Wang J; Ni H; Ran X
    Appl Microbiol Biotechnol; 2020 Apr; 104(7):3011-3023. PubMed ID: 32002602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of specific immunoglobulin A in nasal secretions and neutralizing antibodies in serum collected at multiple time points from young beef calves following intranasal or subcutaneous administration of a modified-live bovine respiratory syncytial virus vaccine.
    Bornheim HN; Chamorro MF; Cernicchiaro N; Reppert EJ; Larson RL; Huser S; Thoresen M; Jones K; Weaber RL; Woolums AR
    Am J Vet Res; 2021 Sep; 82(9):746-751. PubMed ID: 34432517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle.
    Zhu X; Letchworth GJ
    Vaccine; 1996 Jan; 14(1):61-9. PubMed ID: 8821651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination trials against bovine herpesvirus-1.
    Castrucci G; Ferrari M; Salvatori D; Sardonini S; Frigeri F; Petrini S; Lo Dico M; Marchini C; Rotola A; Amici A; Provinciali M; Tosini A; Angelini R; Cassai E
    Vet Res Commun; 2005 Aug; 29 Suppl 2():229-31. PubMed ID: 16244962
    [No Abstract]   [Full Text] [Related]  

  • 48. Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine.
    Loehr BI; Pontarollo R; Rankin R; Latimer L; Willson P; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2001 Dec; 82(Pt 12):3035-3043. PubMed ID: 11714981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal vaccination against infectious bovine rhinotracheitis: studies on early onset of protection and use of the vaccine in pregnant cows.
    Todd JD; Volenec FJ; Paton IM
    J Am Vet Med Assoc; 1971 Dec; 159(11):1370-4. PubMed ID: 4341682
    [No Abstract]   [Full Text] [Related]  

  • 50. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
    Ellis JA; Gow SP; Mahan S; Leyh R
    J Am Vet Med Assoc; 2013 Dec; 243(11):1602-8. PubMed ID: 24261811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fatal, generalized bovine herpesvirus type-1 infection associated with a modified-live infectious bovine rhinotracheitis parainfluenza-3 vaccine administered to neonatal calves.
    Bryan LA; Fenton RA; Misra V; Haines DM
    Can Vet J; 1994 Apr; 35(4):223-8. PubMed ID: 8076277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of a modified-live combination vaccine against respiratory and reproductive diseases in pregnant cows.
    Ellsworth MA; Brown MJ; Fergen BJ; Ficken MD; Tucker CM; Bierman P; TerHune TN
    Vet Ther; 2003; 4(2):120-7. PubMed ID: 14506587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bovine herpesvirus type 1 marker vaccine induces cross-protection against bubaline herpesvirus type 1 in water buffalo.
    Montagnaro S; De Martinis C; Iovane V; Ciarcia R; Damiano S; Nizza S; De Martino L; Iovane G; Pagnini U
    Prev Vet Med; 2014 Sep; 116(1-2):56-62. PubMed ID: 24985155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
    Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
    Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutralizing antibody responses in preconditioned calves following vaccination for respiratory viruses.
    Grooms DL; Coe P
    Vet Ther; 2002; 3(2):119-27. PubMed ID: 19750742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
    Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.
    DesCôteaux L; Cécyre D; Elsener J; Beauchamp G
    Can Vet J; 2003 Oct; 44(10):816-21. PubMed ID: 14601677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle.
    van Drunen Littel-van den Hurk S; Van Donkersgoed J; Kowalski J; van den Hurk JV; Harland R; Babiuk LA; Zamb TJ
    Vaccine; 1994 Nov; 12(14):1295-302. PubMed ID: 7856294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bovine herpesvirus 1 modified live virus vaccines for cattle reproduction: Balancing protection with undesired effects.
    Chase CCL; Fulton RW; O'Toole D; Gillette B; Daly RF; Perry G; Clement T
    Vet Microbiol; 2017 Jul; 206():69-77. PubMed ID: 28377131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.